CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases

Sézary syndrome (SS) is a rare and aggressive type of cutaneous T-cell lymphoma (CTCL). Due to its rarity and marked biological heterogeneity, SS diagnosis is frequently delayed, as it requires the integration of multiple complex diagnostic tests interpreted by highly specialized biomedical figures....

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Giulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, Francesca Passarelli, Cristina Cristofoletti, Maria Cristina Picchio, Laura Bonmassar, Stefania Madonna, Laura Mercurio, Alessandro Monopoli, Filomena Russo, Gaia Moretta, Enrico Scala, Stefania D’Atri, Maria Grazia Narducci
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2026-04-01
Rangatū:	Frontiers in Immunology
Ngā marau:	cutaneous T-cell lymphoma CXCL13 differential diagnostic marker ELISA IHC RT-qPCR
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1804103/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!